China, Life Sciences | JD Supra Law News

China Life Sciences Health Industry Client Briefing – February 2013 (March 11, 2013)

by Vicki Lung, Mao Rong, Gordon B. Schatz, John Tan, May Ling Wong, Jay J. Yan, Katherine Yang, Amy Yin | Reed Smith on 3/12/2013

In This Issue: New Drug GSP Issued: Supervision on Drug Distribution to be Enhanced (China Securities Journal 2013-02-20) – February 20, 2013; China to Encourage Innovative Drug Development (Xinhua News Agency...more

China Life Sciences Health Industry Client Briefing – January 2013 (February 21, 2013)

by Vicki Lung, Mao Rong, Gordon B. Schatz, John Tan, May Ling Wong, Jay J. Yan, Katherine Yang, Amy Yin | Reed Smith on 2/22/2013

In This Issue: Li Keqiang Comments from the 12th Plenary Meeting of the Medical Reform Leading Group (USCBC 2012-01-06) – January 6, 2013; MOH Announces Roadmap for Medical Reform (USCBC 2012-01-10) – January 10, 2013;...more

China Life Sciences Health Industry Client Briefing - December 2012 (January 18, 2013)

by Vicki Lung, Mao Rong, Gordon B. Schatz, John Tan, May Ling Wong, Jay J. Yan, Katherine Yang | Reed Smith on 1/24/2013

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - News & Regulations: ..Industry Calls for Reform of Lagging Drug Review System (Global Times 2012-12-02) – December 3, 2012...more

Skadden's 2013 Insights

by Skadden, Arps, Slate, Meagher & Flom LLP on 1/18/2013

We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013. There is hope that global economic and market conditions will continue to improve despite ongoing...more

China Life Sciences - January 2013

by Gabriel Bloch, Peng Chen, Gordon Milner, Kun Wang | Morrison & Foerster LLP on 1/17/2013

In This Issue: Investor Q&A; Key Regulatory Issues for Strategic Life Sciences Partnerships in China; Compulsory Patent Licensing in China; and New Developments on the “Patentable Subject Matter” Requirement of U.S....more

China Life Sciences and Health Industry Client Briefing – November 2012 (December 13, 2012)

by Mao Rong, Gordon B. Schatz, Hugh T. Scogin , Jr., John Tan, May Ling Wong, Jay J. Yan, Katherine Yang, Amy Yin | Reed Smith on 12/17/2012

In This Issue: Priorities, Practical Tips and Lessons Learned from Reed Smith’s China Device Regulatory Briefing on December 4, 2012; Programs of Designated Drug Production to be Initiated: Five to 10 Pilot Varieties...more

China Life Sciences and Health Industry Client Briefing – October 2012 (November 16, 2012)

by Reed Smith on 11/20/2012

In This Issue: - China Becoming Healthcare R&D Hub (China Daily 2012-10-09) – October 9, 2012 - Imported Drugs to Go on China's Electronic Monitoring Network (Xinhua News Agency 2012-10-08) – October 9, 2012...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

by Reed Smith on 10/5/2012

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

China Life Sciences and Health Industry Client Briefing – July 2012 (August 8, 2012)

by Reed Smith on 8/9/2012

In This Issue: - Counterfeit Drug Crackdown in China (Xinhua News Agency 2012-08-05) – August 5, 2012 - China Agencies Drafting Policies to Accelerate Development of Medical Devices, Supporting Fund to be...more

Life Sciences Health Industry China Briefing - June 2012 (July 20, 2012)

by Reed Smith on 7/26/2012

In This Issue: - China's Compulsory License Rule Has Drug Companies On Edge (Law360 2012-06 12) — June 14, 2012 - Beijing to Carry out Pilot Project of Separation of Dispensing from Prescription: Medical...more

Life Sciences Health Industry China Briefing – May 2012 (June 14, 2012)

by Reed Smith on 6/15/2012

In This Issue: News - Introduction of Administrative Measures on Clinical Application of Antimicrobial Drugs (Ministry of Health 2012-05-08) – May 9, 2012 The Ministry of Health recently issued the...more

China Life Sciences Newsletter -- April 2012

by Morrison & Foerster LLP on 4/26/2012

In This Issue: *Investor Q&A *Trends and Best Practices in R&D Strategic Partnerships in China *USPTO Proposed Rules on Preissuance Submissions Excerpt from Investor Q&A Interview by Chuck Comey,...more

CHINA BRIEFING January 2012 (February 13, 2012) - Pharmaceuticals, Devices, Health Care & Life Sciences

by Reed Smith on 2/16/2012

In This Issue: Regulations & News Excerpt from Regulations • Notice from the Ministry of Health concerning the Outline of China’s Nursing Development Plan from 2011 to 2015 – January 9, 2012 On...more

China Life Sciences - December 2011

by Morrison & Foerster LLP on 12/19/2011

In this issue: Investor Q&A; Implications of the Leahy-Smith America Invents Act for Chinese Life Science Companies; Frequent Issues Arising in Acquisitions of China Life Sciences Targets; and Key Regulatory...more

China Life Sciences: Moving Towards Full Impact

by Morrison & Foerster LLP on 8/16/2010

I recently spent some time in the “Golden Triangle,” which on its Northern edge is delineated by the area between Nanjing and Shanghai. What is initially striking is the absolutely mammoth investment in infrastructure that...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

China › Life Sciences